<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Medical treatments for patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and class II and above <z:hpo ids='HP_0001513'>obesity</z:hpo> (body mass index greater than 35 kg/m2) are currently limited to treatment of <z:mp ids='MP_0002055'>diabetes</z:mp> and prevention of its vascular complications </plain></SENT>
<SENT sid="1" pm="."><plain>Bariatric surgery is by far the most effective treatment not only for <z:hpo ids='HP_0001824'>weight loss</z:hpo>, but also for improvement or remission of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>This editorial examines the current evidence for the impact of bariatric surgery on <z:hpo ids='HP_0001824'>weight loss</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>